author-photo

Jodi Cooper

Takeda Pharmaceutical Company

1

Papers

1

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Abstract B189: MLN0128, an investigational mTORC1/2 inhibitor, demonstrates potent antitumor activity alone and in combination with paclitaxel in preclinical models of endometrial cancer.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)